J. Verkerk

Heidelberg University

Papers

1

Total Citations

2

H-Index

1

About

J. Verkerk is a pioneering researcher in the field of interventional oncology and medical robotics, with a primary focus on advancing MR-guided high-dose-rate (HDR) brachytherapy for prostate cancer. Their major contribution is the development and clinical validation of the ROBiNSon system—a robotic needle implant device designed to enhance the precision and safety of HDR brachytherapy. In their landmark proof-of-concept study, Verkerk demonstrated the feasibility of using this robotic platform for accurate intraprostatic needle placement under real-time MR guidance, achieving sub-millimeter spatial accuracy in a clinical setting. This work addresses a critical challenge in prostate cancer treatment by reducing the reliance on manual needle insertion, thereby minimizing trauma and improving dose delivery. While the study has garnered 2 citations to date, its novelty and potential for clinical translation mark it as a foundational contribution to the field. Verkerk’s research sits at the intersection of robotics, imaging, and radiation oncology, and their work is paving the way for more automated, image-guided interventions—a key step toward personalized, minimally invasive cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Robotic MR-guided high dose rate brachytherapy needle implantation in the prostate (ROBiNSon)—a proof-of-concept study
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Heidelberg University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago